Latham & Watkins Advises Cerner in US$28.3 Billion Acquisition by Oracle

Oracle Corporation (NYSE: ORCL) and Cerner Corporation have jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for US$95.00 per share, or approximately US$28.3 billion in equity value. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities.

Latham & Watkins LLP represents Cerner in the transaction with a corporate deal team led by Chicago partner Mark Gerstein, Century City partner James Beaubien, and Chicago partner Christopher Drewry, with associates Sean McDermott Parish, Aidan Milstead, and Jake Wasserman. Advice was also provided on antitrust matters by Washington, D.C. partners Amanda Reeves and Ian Conner and Brussels partner Hector Armengod; on benefits and compensation matters by Los Angeles partner Michelle Carpenter, with associate Vanessa King; on data privacy matters by Bay Area counsel Heather Deixler, with associate Heather Lui; on environmental matters by Los Angeles partner Maria Pilar Hoye and Los Angeles counsel Aron Potash; on FCPA matters by Chicago partner Meredith Monroe, with associate Joseph Grosser; on finance matters by Chicago partner Cindy Caillavet Sinclair, with associate Katherine Stork; on government contracts matters by Washington, D.C. counsels Dean Baxtresser and Kyle Jefcoat; on healthcare regulatory matters by Los Angeles partner Daniel Settelmayer, with associate Felicia Alexander; on intellectual property matters by Orange County partner David Kuiper, with associate Veronica Ye; on litigation matters by Orange County partner Michele Johnson and San Diego partner Colleen Smith; on real estate matters by Los Angeles partner Kim Boras; on securities matters by Century City partner Brent Epstein, with associate Andrew Rutsky; on tax matters by Bay Area partner Grace Lee, with associate Jake Meninga; and on trade controls and sanctions matters by Washington, D.C. associate Andrew Galdes.